Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.
Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
Aptinyx Inc. is a biopharmaceutical company.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Syremis Therapeutics is developing novel medicines to make a profound impact on the treatment of mental health disorders.
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Apreo Health is developer of medical apparatus designed for diagnosing or treating respiratory, pulmonary, and lung conditions.
Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.
Interius BioTherapeutics is a biotechnology company that delivers genetic medicines for patients.
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Serán Bioscience is a contract development and manufacturing organization.
Bain Capital Life Sciences has invested in 59 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Bain Capital Life Sciences's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Kailera Therapeutics received $600.0M in a Series B round. Bain Capital Life Sciences's total known invested capital is $10.0B.
Bain Capital Life Sciences's average investment size is $169.7M across its portfolio of 59 companies.
Recent Bain Capital Life Sciences portfolio additions include SpringWorks Therapeutics, Aiolos Bio, Upstream Bio, Alkeus Pharmaceuticals, 2seventy bio. These companies were founded in 2020 or later.